当前位置:首页 - 行情中心 - 精华制药(002349) - 财务分析 - 现金流量表

精华制药

(002349)

  

流通市值:58.54亿  总市值:59.76亿
流通股本:8.14亿   总股本:8.31亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金340,014,082.741,471,942,8681,090,553,738.46712,736,551.48
  收到的税费返还26,943.37144,166.78140,411.5136,020.36
  收到其他与经营活动有关的现金6,140,050.1931,085,328.4334,800,496.1422,814,198.86
  经营活动现金流入小计346,181,076.31,503,172,363.211,125,494,646.11735,586,770.7
  购买商品、接受劳务支付的现金120,634,463.88480,174,906.93374,113,694.97244,518,755.38
  支付给职工以及为职工支付的现金103,755,059.9331,662,625.6262,339,809.71182,775,435.31
  支付的各项税费37,869,939.62162,275,740.95125,589,604.5783,426,414.49
  支付其他与经营活动有关的现金47,466,604.33188,192,839.7138,891,836.797,179,832.48
  经营活动现金流出小计309,726,067.731,162,306,113.18900,934,945.95607,900,437.66
  经营活动产生的现金流量净额36,455,008.57340,866,250.03224,559,700.16127,686,333.04
二、投资活动产生的现金流量:
  收回投资收到的现金328,250,0001,274,195,725.42878,000,000681,000,000
  取得投资收益收到的现金1,850,192.365,819,164.53,244,899.392,188,021.2
  处置固定资产、无形资产和其他长期资产收回的现金净额-47,20031,00031,000
  收到的其他与投资活动有关的现金10,144,833.3310,618,402.7810,618,402.78-
  投资活动现金流入小计340,245,025.691,290,680,492.7891,894,302.17683,219,021.2
  购建固定资产、无形资产和其他长期资产支付的现金7,024,469.3220,323,490.9313,639,408.369,017,610.45
  投资支付的现金289,000,0001,598,950,0001,233,700,000865,700,000
  支付其他与投资活动有关的现金84,043,277.78141,000,000121,051,082.31121,000,000
  投资活动现金流出小计380,067,747.11,760,273,490.931,368,390,490.67995,717,610.45
  投资活动产生的现金流量净额-39,822,721.41-469,592,998.23-476,496,188.5-312,498,589.25
三、筹资活动产生的现金流量:
  吸收投资收到的现金-56,708,04056,708,04056,708,040
  取得借款收到的现金3,000,000-200,000-
  收到其他与筹资活动有关的现金154,7805,439,526.478,2968,296
  筹资活动现金流入小计3,154,78062,147,566.4756,916,33656,716,336
  偿还债务支付的现金200,00010,000,00010,000,00010,000,000
  分配股利、利润或偿付利息支付的现金12,75084,990,973.0184,948,612.984,948,612.9
  其中:子公司支付给少数股东的股利、利润-19,747,160--
  支付其他与筹资活动有关的现金188,818869,253.69662,935.69573,685.69
  筹资活动现金流出小计401,56895,860,226.795,611,548.5995,522,298.59
  筹资活动产生的现金流量净额2,753,212-33,712,660.23-38,695,212.59-38,805,962.59
四、汇率变动对现金及现金等价物的影响-1,597,926.44-2,272,865.34-1,402,722.56-432,880.12
五、现金及现金等价物净增加额-2,212,427.28-164,712,273.77-292,034,423.49-224,051,098.92
  加:期初现金及现金等价物余额848,808,462.71,013,520,736.471,013,520,736.471,013,520,736.47
  期末现金及现金等价物余额846,596,035.42848,808,462.7721,486,312.98789,469,637.55
补充资料:
  净利润-261,835,558.5-151,686,598.43
  资产减值准备-11,206,135.61-4,927,023.94
  固定资产和投资性房地产折旧-77,485,379.56-37,645,326.04
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-77,485,379.56-37,645,326.04
  无形资产摊销-2,113,806-1,072,945.74
  处置固定资产、无形资产和其他长期资产的损失-5,092.86--28,384.68
  固定资产报废损失-1,140,894.18--
  公允价值变动损失--4,173,858.83--1,451,220.5
  财务费用--7,435,991.06--2,881,097.39
  投资损失--3,572,027.3--1,434,037.28
  递延所得税-1,333,582.11-334,193.16
  其中:递延所得税资产减少--998,246.67--23,703.23
    递延所得税负债增加-2,331,828.78-357,896.39
  存货的减少--17,727,553.88--12,659,133.76
  经营性应收项目的减少--13,202,694.66--55,089,953.71
  经营性应付项目的增加-13,187,260.07-5,016,187.49
  其他-17,685,033.02--
  融资租入固定资产-2,361,642.28--
  现金的期末余额-848,808,462.7-789,469,637.55
  减:现金的期初余额-1,013,520,736.47-1,013,520,736.47
  现金及现金等价物的净增加额--164,712,273.77--224,051,098.92
公告日期2026-04-302026-04-232025-10-302025-08-30
审计意见(境内)标准无保留意见
TOP↑